Skip to main content

MDS Sciex, Eksigent in Proteomics Co-Marketing Pact

NEW YORK June 3 - MDS Sciex will co-market and distribute microfluidics technology for proteomics research developed by Eksigent Technologies, the companies said today.

 

MDS Sciex will globally co-market and distribute Eksigent's NanoLC system, a high-performance liquid chromatography system for nanoscale liquid chromatography/mass spectrometry experiments.

 

According to Eksigent, the NanoLC system can be used as stand-alone product or in LC/MS identification of peptides for proteomics studies.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.